We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.47B
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
$173M 4.11%
2,335,615
+350
+0% +$24.4K
BHC icon
2
Bausch Health
BHC
$2.36B
$168M 3.98%
1,328,220
-184,310
-12% -$23.5M
AMG icon
3
Affiliated Managers Group
AMG
$9.59B
$139M 3.31%
678,435
– –
GILD icon
4
Gilead Sciences
GILD
$181B
$138M 3.29%
1,670,135
+55,180
+3% +$4.3M
ORLY icon
5
O'Reilly Automotive
ORLY
$71.6B
$115M 2.72%
11,405,010
– –
TMO icon
6
Thermo Fisher Scientific
TMO
$230B
$114M 2.71%
965,976
-375
-0% -$44.1K
SNA icon
7
Snap-on
SNA
$20.3B
$112M 2.67%
946,850
-295
-0% -$34.1K
AON icon
8
Aon
AON
$75.4B
$111M 2.65%
1,236,220
– –
MSFT icon
9
Microsoft
MSFT
$3.81T
$101M 2.41%
2,430,050
+7,900
+0.3% +$320K
CBRE icon
10
CBRE Group
CBRE
$43.7B
$96.4M 2.29%
3,008,715
-10,300
-0.3% -$297K
KMI icon
11
Kinder Morgan
KMI
$70.3B
$92.4M 2.2%
2,548,765
+51,650
+2% +$1.74M
BALL icon
12
Ball Corp
BALL
$16.9B
$92.4M 2.2%
2,948,872
– –
DVA icon
13
DaVita
DVA
$11.5B
$86.3M 2.05%
1,193,598
-3,800
-0.3% -$264K
TGNA
14
DELISTED
TEGNA Inc
TGNA
$85.7M 2.04%
5,232,454
+311,516
+6% +$4.57M
LKQ icon
15
LKQ Corp
LKQ
$6.46B
$84.2M 2%
3,153,423
+64,740
+2% +$1.79M
GWW icon
16
W.W. Grainger
GWW
$61.5B
$75M 1.78%
295,070
+600
+0.2% +$153K
PII icon
17
Polaris
PII
$3.63B
$73.8M 1.75%
566,979
-61,695
-10% -$8.17M
KMR
18
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$72.1M 1.71%
943,197
+647
+0.1% +$45.9K
ATR icon
19
AptarGroup
ATR
$8.46B
$70.7M 1.68%
1,055,260
-240
-0% -$16K
JCI icon
20
Johnson Controls International
JCI
$84.6B
$70.5M 1.68%
1,348,594
+304,010
+29% +$15.1M
CPRT icon
21
Copart
CPRT
$30.5B
$69.6M 1.65%
15,492,680
– –
ORCL icon
22
Oracle
ORCL
$435B
$66.6M 1.58%
1,642,765
+2,625
+0.2% +$108K
CB icon
23
Chubb
CB
$131B
$64.8M 1.54%
625,310
+188,350
+43% +$19.3M
PFE icon
24
Pfizer
PFE
$159B
$63.9M 1.52%
2,270,558
+971,993
+75% +$27.7M
COV
25
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$62.4M 1.48%
691,815
-5,500
-0.8% -$411K
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.